137 related articles for article (PubMed ID: 37294133)
41. Clinical efficacy of mogamulizumab for relapsed/refractory aggressive adult T-cell leukemia/lymphoma: A retrospective analysis.
Satake A; Konishi A; Azuma Y; Tsubokura Y; Yoshimura H; Hotta M; Nakanishi T; Fujita S; Nakaya A; Ito T; Ishii K; Nomura S
Eur J Haematol; 2020 Dec; 105(6):704-711. PubMed ID: 32564395
[TBL] [Abstract][Full Text] [Related]
42. [Mogamulizumab for the treatment of ATL and PTCL].
Tsukasaki K
Gan To Kagaku Ryoho; 2015 May; 42(5):553-7. PubMed ID: 26054089
[No Abstract] [Full Text] [Related]
43. [Development of mogamulizumab and establishment of an optimal therapy based on genomic biomarkers: from the academic viewpoint].
Iida S; Ishida T; Ueda R
Yakugaku Zasshi; 2015; 135(5):663-9. PubMed ID: 25948299
[TBL] [Abstract][Full Text] [Related]
44. Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma.
Yamamoto K; Utsunomiya A; Tobinai K; Tsukasaki K; Uike N; Uozumi K; Yamaguchi K; Yamada Y; Hanada S; Tamura K; Nakamura S; Inagaki H; Ohshima K; Kiyoi H; Ishida T; Matsushima K; Akinaga S; Ogura M; Tomonaga M; Ueda R
J Clin Oncol; 2010 Mar; 28(9):1591-8. PubMed ID: 20177026
[TBL] [Abstract][Full Text] [Related]
45. Therapeutic Efficacy of Etretinate on Cutaneous-type Adult T-cell Leukemia-Lymphoma.
Yonekura K; Takeda K; Kawakami N; Kanzaki T; Kanekura T; Utsunomiya A
Acta Derm Venereol; 2019 Jul; 99(9):774-776. PubMed ID: 31017247
[TBL] [Abstract][Full Text] [Related]
46. Dosing of a phase I study of KW-0761, an anti-CCR4 antibody, for adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma.
Suzuki R
J Clin Oncol; 2010 Aug; 28(23):e404-5; author reply e406. PubMed ID: 20566994
[No Abstract] [Full Text] [Related]
47. Successful treatment with brentuximab vedotin for relapsed and refractory adult T cell leukemia.
Oka S; Ono K; Nohgawa M
Anticancer Drugs; 2020 Jun; 31(5):536-539. PubMed ID: 31934889
[TBL] [Abstract][Full Text] [Related]
48. Molecular analysis of loss of CCR4 expression during mogamulizumab monotherapy in an adult T cell leukemia/lymphoma patient.
Taguchi M; Imaizumi Y; Sasaki D; Higuchi T; Tsuruda K; Hasegawa H; Taguchi J; Sawayama Y; Imanishi D; Hata T; Yanagihara K; Yoshie O; Miyazaki Y
Ann Hematol; 2015 Apr; 94(4):693-5. PubMed ID: 25338968
[No Abstract] [Full Text] [Related]
49. Recent advances in the treatment of adult T-cell leukemia-lymphomas.
Utsunomiya A; Choi I; Chihara D; Seto M
Cancer Sci; 2015 Apr; 106(4):344-51. PubMed ID: 25613789
[TBL] [Abstract][Full Text] [Related]
50. [Companion diagnostics "POTELIGEO TEST IHC/FCM" used with "POTELIGEO" (mogamulizumab) for adult T-cell leukemia-lymphoma (ATL) treatment].
Goami T
Rinsho Byori; 2014 May; 62(5):450-6. PubMed ID: 25051659
[TBL] [Abstract][Full Text] [Related]
51. Unilateral conjunctival infiltration of Adult T-cell leukemia/lymphoma. Case report and literature review.
Shimono J; Kaino S; Okada K; Oshimi K; Ishida Y; Takahashi T; Miyagishima T; Teshima T
J Clin Exp Hematop; 2017; 57(3):143-146. PubMed ID: 29279551
[TBL] [Abstract][Full Text] [Related]
52. Mogamulizumab: a new tool for management of cutaneous T-cell lymphoma.
Ollila TA; Sahin I; Olszewski AJ
Onco Targets Ther; 2019; 12():1085-1094. PubMed ID: 30799938
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of mammalian target of rapamycin signaling by everolimus induces senescence in adult T-cell leukemia/lymphoma and apoptosis in peripheral T-cell lymphomas.
Darwiche N; Sinjab A; Abou-Lteif G; Chedid MB; Hermine O; Dbaibo G; Bazarbachi A
Int J Cancer; 2011 Aug; 129(4):993-1004. PubMed ID: 21064094
[TBL] [Abstract][Full Text] [Related]
54. Mogamulizumab for adult T-cell leukemia-lymphoma: a multicenter prospective observational study.
Yonekura K; Kusumoto S; Choi I; Nakano N; Ito A; Suehiro Y; Imaizumi Y; Yoshimitsu M; Nosaka K; Ohtsuka E; Hidaka M; Jo T; Sasaki H; Moriuchi Y; Ogata M; Tatetsu H; Ishitsuka K; Miyazaki Y; Ueda R; Utsunomiya A; Ishida T
Blood Adv; 2020 Oct; 4(20):5133-5145. PubMed ID: 33091125
[TBL] [Abstract][Full Text] [Related]
55. CCR4 mutations associated with superior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatment.
Sakamoto Y; Ishida T; Masaki A; Murase T; Yonekura K; Tashiro Y; Tokunaga M; Utsunomiya A; Ito A; Kusumoto S; Iida S; Ueda R; Inagaki H
Blood; 2018 Aug; 132(7):758-761. PubMed ID: 29930010
[No Abstract] [Full Text] [Related]
56. Mogamulizumab and the treatment of CCR4-positive T-cell lymphomas.
Remer M; Al-Shamkhani A; Glennie M; Johnson P
Immunotherapy; 2014; 6(11):1187-206. PubMed ID: 25496334
[TBL] [Abstract][Full Text] [Related]
57. Paraffin-immunohistochemical analysis of 226 non-Hodgkin's malignant lymphomas in the endemic area of human T-cell leukemia virus type 1.
Hasui K
Acta Pathol Jpn; 1991 May; 41(5):350-62. PubMed ID: 1867099
[TBL] [Abstract][Full Text] [Related]
58. Epstein-Barr virus-related diffuse large B-cell lymphoma in mogamulizumab-treated adult T-cell leukemia with incomplete T-cell reconstitution.
Kamachi K; Shindo T; Miyahara M; Kitaura K; Akashi M; Shin-I T; Suzuki R; Oshima K; Kimura S
Int J Hematol; 2019 Feb; 109(2):221-227. PubMed ID: 30368656
[TBL] [Abstract][Full Text] [Related]
59. Primary and secondary T-cell lymphomas of the breast: clinico-pathologic features of 11 cases.
Gualco G; Chioato L; Harrington WJ; Weiss LM; Bacchi CE
Appl Immunohistochem Mol Morphol; 2009 Jul; 17(4):301-6. PubMed ID: 19318917
[TBL] [Abstract][Full Text] [Related]
60. Adult T-cell leukaemia/lymphoma.
Matutes E
J Clin Pathol; 2007 Dec; 60(12):1373-7. PubMed ID: 18042693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
